0001562180-20-001234.txt : 20200214
0001562180-20-001234.hdr.sgml : 20200214
20200214163614
ACCESSION NUMBER: 0001562180-20-001234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ordentlich Peter
CENTRAL INDEX KEY: 0001594274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 20620975
MAIL ADDRESS:
STREET 1: C/O SYNDAX PHARMACEUTICALS, INC.
STREET 2: 400 TOTTEN POND ROAD, SUITE 140
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-02-12
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001594274
Ordentlich Peter
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
false
true
false
false
Chief Scientific Officer
Stock Option (Right to Buy)
9.47
2020-02-12
4
A
false
50000.00
0.00
A
2030-02-12
Common Stock
50000.00
50000.00
D
1/48th of the shares subject to the option shall vest monthly over a four-year period.
/s/ Michael A. Metzger, Attorney-in-Fact
2020-02-14